- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zim Laboratories Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting
11-02-2026 | 07:09 pm
11-02-2026 | 07:09 pm
ZIMLAB's board has approved its Q3 & 9M financial results. Consolidated Q3 revenue hit ₹108.66 Cr with PAT at ₹4.40 Cr. For the nine months, revenue stood at ₹269.13 Cr and PAT at ₹2.10 Cr. EPS for Q3 was ₹0.90.
No comments yet. Be the first to comment!